Literature DB >> 11447259

Tbx19, a tissue-selective regulator of POMC gene expression.

J Liu1, C Lin, A Gleiberman, K A Ohgi, T Herman, H P Huang, M J Tsai, M G Rosenfeld.   

Abstract

Pituitary cell types arise in a temporally and spatially specific fashion, in response to combinatorial actions of transcription factors induced by transient signaling gradients. The critical transcriptional determinants of the two pituitary cell types that express the pro-opiomelanocortin (POMC) gene, the anterior lobe corticotropes, producing adrenocorticotropin, and the intermediate lobe melanotropes, producing melanocyte-stimulating hormone (MSH alpha), have remained unknown. Here, we report that a member of the T-box gene family, Tbx19, which is expressed only in the rostral ventral diencephalon and pituitary gland, commencing on e11.5, marks pituitary cells that will subsequently express the POMC gene and is capable of altering progression of ventral cell types and inducing adrenocorticotropin in rostral tip cells. It is suggested that Tbx19, depending on the presence of synergizing transcription factors, can activate POMC gene expression and repress the alpha glycoprotein subunit and thyroid-stimulating hormone beta promoters.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447259      PMCID: PMC37494          DOI: 10.1073/pnas.141234898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Leukemia inhibitory factor as an intrapituitary regulator of pro-opiomelanocortin gene expression and corticotrope ontogeny.

Authors:  L Guignat; J Bertherat
Journal:  Eur J Endocrinol       Date:  1999-09       Impact factor: 6.664

2.  Tissue interactions in the induction of anterior pituitary: role of the ventral diencephalon, mesenchyme, and notochord.

Authors:  A S Gleiberman; N G Fedtsova; M G Rosenfeld
Journal:  Dev Biol       Date:  1999-09-15       Impact factor: 3.582

3.  Differential DNA binding and transcription modulation by three T-box proteins, T, TBX1 and TBX2.

Authors:  S Sinha; S Abraham; R M Gronostajski; C E Campbell
Journal:  Gene       Date:  2000-11-27       Impact factor: 3.688

Review 4.  T-targets: clues to understanding the functions of T-box proteins.

Authors:  M Tada; J C Smith
Journal:  Dev Growth Differ       Date:  2001-02       Impact factor: 2.053

5.  Tbx5 and Tbx4 genes determine the wing/leg identity of limb buds.

Authors:  J K Takeuchi; K Koshiba-Takeuchi; K Matsumoto; A Vogel-Höpker; M Naitoh-Matsuo; K Ogura; N Takahashi; K Yasuda; T Ogura
Journal:  Nature       Date:  1999-04-29       Impact factor: 49.962

6.  Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.

Authors:  C Bousquet; M C Zatelli; S Melmed
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

7.  The T-box genes Tbx4 and Tbx5 regulate limb outgrowth and identity.

Authors:  C Rodriguez-Esteban; T Tsukui; S Yonei; J Magallon; K Tamura; J C Izpisua Belmonte
Journal:  Nature       Date:  1999-04-29       Impact factor: 49.962

8.  Specific protein-protein interaction between basic helix-loop-helix transcription factors and homeoproteins of the Pitx family.

Authors:  G Poulin; M Lebel; M Chamberland; F W Paradis; J Drouin
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation.

Authors:  M Maira; C Martens; A Philips; J Drouin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

10.  Transcription repression by Xenopus ET and its human ortholog TBX3, a gene involved in ulnar-mammary syndrome.

Authors:  M l He; L Wen; C E Campbell; J Y Wu; Y Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

View more
  44 in total

Review 1.  Series introduction. The immuno-neuroendocrine interface.

Authors:  S Melmed
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  From panhypopituitarism to combined pituitary deficiencies: do we need the anterior pituitary?

Authors:  Catherine Carrière; Anatoli Gleiberman; Chijen R Lin; Michael G Rosenfeld
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

Review 3.  The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Anne Maria Möller-Leimkühler; Giancarlo Giupponi; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-20       Impact factor: 5.270

Review 4.  Signaling and epigenetic regulation of pituitary development.

Authors:  Xiaoyan Zhu; Jianxun Wang; Bong-Gun Ju; Michael G Rosenfeld
Journal:  Curr Opin Cell Biol       Date:  2007-11-07       Impact factor: 8.382

5.  Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene promoter by the DNA-binding protein Finb/RREB-1.

Authors:  Subir K Ray; Junko Nishitani; Mary W Petry; Michael Y Fessing; Andrew B Leiter
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 6.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

7.  MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8.

Authors:  Nan Zhang; Jun-kai Lin; Juan Chen; Xiong-fei Liu; Jia-li Liu; Hao-shu Luo; Yue-qin Li; Sheng Cui
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

8.  The basic helix-loop-helix transcription factor NeuroD1 facilitates interaction of Sp1 with the secretin gene enhancer.

Authors:  Subir K Ray; Andrew B Leiter
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

9.  Premature differentiation and aberrant movement of pituitary cells lacking both Hes1 and Prop1.

Authors:  Ashley D Himes; Lori T Raetzman
Journal:  Dev Biol       Date:  2008-11-01       Impact factor: 3.582

Review 10.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.